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In the adult mammalian brain, new neurons continue to be produced throughout life
in two main regions in the brain, the subgranular zone (SGZ) in the hippocampus
and the subventricular zone in the walls of the lateral ventricles. Neural stem cells
(NSCs) proliferate in these niches, and migrate as neuroblasts, to further differentiate
in locations where new neurons are needed, either in normal or pathological conditions.
However, the endogenous attempt of brain repair is not very efficient. Calpains are
proteases known to be involved in neuronal damage and in cell proliferation, migration
and differentiation of several cell types, though their effects on neurogenesis are not well
known. Previous work by our group has shown that the absence of calpastatin (CAST),
the endogenous inhibitor of calpains, impairs early stages of neurogenesis. Since the
hippocampus is highly associated with learning and memory, we aimed to evaluate
whether calpain inhibition would help improve cognitive recovery after lesion and
efficiency of post-injury neurogenesis in this region. For that purpose, we used the kainic
acid (KA) model of seizure-induced hippocampal lesion and mice overexpressing CAST.
Selected cognitive tests were performed on the 3rd and 8th week after KA-induced
lesion, and cell proliferation, migration and differentiation in the dentate gyrus (DG) of the
hippocampus of adult mice were analyzed using specific markers. Cognitive recovery
was evaluated by testing the animals for recognition, spatial and associative learning and
memory. Cognitive function was preserved by CAST overexpression following seizures,
while modulation of post-injury neurogenesis was similar to wild type (WT) mice. Calpain
inhibition could still be potentially able to prevent the impairment in the formation of
new neurons, given that the levels of calpain activity could be reduced under a certain
threshold and other harmful effects from the pathological environment could also be
controlled.
Keywords: calpains, calpastatin, cognition, hippocampus, post-injury neurogenesis
Abbreviations: BrdU, 5-bromo-2′-deoxyuridine; CAST, calpastatin; DCX, doublecortin; DG, dentate gyrus;
EdU, 5-ethynyl-2′-deoxyuridine; FC, fear conditioning; GZ, granular zone; hCAST, mice overexpressing calpastatin;
KA, kainic acid; NeuN, neuronal nuclei; NSC, neural stem cell; OR, object recognition; SAL, saline; SGZ, subgranular
zone; WM, water maze; WT, wild type.
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INTRODUCTION
New neurons in the adult mammalian brain are known to
originate from mainly two regions, the subventricular zone, in
the walls of the lateral ventricles, and the subgranular zone (SGZ),
in the dentate gyrus (DG) of the hippocampus (Bond et al.,
2015). Neural stem cells (NSCs) from the subventricular zone
migrate long distances, through a rostral migratory stream, into
the olfactory bulb, differentiating into interneurons. NSCs from
the SGZ, in turn, migrate shorter distances into the granular
zone (GZ), where they fully mature into granule neurons
after 2 months (Aimone et al., 2014; Jin, 2016). Functions of
these newborn cells from both regions have been consistently
associated with learning and memory (Deng et al., 2010; Lazarini
and Lledo, 2011).
When a brain lesion occurs, behavioral traits and adult
neurogenesis can become altered. In neurodegenerative diseases,
neurogenesis is mostly hampered, but in acute disorders, such
as temporal lobe epilepsy, NSC proliferation can increase, in a
possible attempt to repair the damage. However, this repair is
limited by impaired cell migration or decreased survival of new
neurons (Kaneko and Sawamoto, 2009; Ma et al., 2009).
Another feature of brain damage is excitotoxicity, which
leads to an increase of cellular levels of calcium, activating
several proteases, including calpains (Neumar et al., 2001).
Calpains are ubiquitously expressed calcium-activated proteases,
with only one known natural endogenous inhibitor, a protein
called calpastatin (CAST; Murachi, 1984). In the CNS, calpain
inhibition has been shown to afford neuroprotection, showing
improved neuronal function and limiting neuronal damage
in several brain disorders (Saez et al., 2006). Although little
is known about their contribution to neurogenesis, calpains
were seen to be involved in cell proliferation, migration and
differentiation in other systems (Rock et al., 2000; Yajima and
Kawashima, 2002; Lokuta et al., 2003; Parnaud et al., 2005; Qiu
et al., 2006; Shimada et al., 2008; Kashiwagi et al., 2010; Kuchay
et al., 2012).
Previous studies by our group show that increased calpain
activity, through lack of CAST, can impair early stages of
neurogenesis in the hippocampus, the main structure involved
in learning and memory (Machado et al., 2015). Moreover,
the kainic acid (KA) model of seizure-induced hippocampal
lesion presents excitotoxic damage mediated by calpains (Araújo
et al., 2008) and is characterized by pathologic alterations in
hippocampal neurogenesis (Carreira et al., 2010).With this work,
we proposed to assess whether overexpression of CAST (hCAST




Three-month old male and female hCAST mice (Rao et al.,
2008), in a C57BL/6 background, and their wild type (WT)
littermates, were used in this study. hCAST mice present
CAST overexpression, due to the cloning of a human CAST
construct (Hitomi et al., 1998) into a Thymocyte differentiation
antigen 1.1 expression cassette (Thy1). The animals were kept
in our animal facilities, in a room with controlled temperature
(21 ± 1◦C) and humidity (55%), with food and water ad libitum
in a 12-h dark:light cycle. All experiments were performed
in accordance with institutional and European guidelines
(2010/63/EU) for the care and use of laboratory animals. The
procedures performed in mice described in this work have
been reviewed and approved by the Animal Welfare Body of
the Center for Neuroscience and Cell Biology and have been
approved by the Direcção Geral de Alimentação e Veterinária
(reference 0421/000/000/2013).
KA Treatment
Hippocampal damage was induced by administering KA
subcutaneously (25 mg/kg, in a concentration of 5 mg/ml,
in a saline (SAL) solution of 0.9% NaCl), as previously
described by our group (Carreira et al., 2010). After KA
administration, the animals went through several stages,
according to a well-defined scale (Schauwecker and Steward,
1997): immobility (I), tail/forelimb extension/rigid posture (II),
repetitive movements/head bobbing (III), rearing and falling
(IV), continuous rearing and falling (V), severe tonic-clonic
seizures (VI). Only mice that reached stage V or higher were used
in this study. SAL-treated animals were used as controls.
Behavior Analysis and Neuronal
Differentiation
For the studies of short-term behavioral recovery, three different
behavioral tests were performed in WT and hCAST mice, on
the 3rd week after KA or SAL treatment (Figure 1A): object
recognition (OR; Figure 1C), water maze (WM; Figure 1D) and
fear conditioning (FC; Figure 1E), as explained further in more
detail. To assess long-term behavioral recovery and neuronal
differentiation after lesion, WT and hCAST mice were treated
as shown in Figure 1B. The thymidine analog 5-ethynyl-2′-
deoxyuridine (EdU) was intraperitoneally administered to WT
and hCAST mice on days 3, 4 and 5 after KA or SAL treatment,
and the animals were sacrificed by transcardial perfusion after
8 weeks, when new neurons are fully mature (Aimone et al.,
2014). Behavioral analysis was performed during the last week.
Object Recognition
For the study of recognition memory, the OR test (Bevins and
Besheer, 2006) was used. Mice were presented to two similar
objects, following habituation to the apparatus (40× 40× 40 cm3
acrylic box), after which one of the objects was replaced by a
novel one. Each stage of the test had the duration of 5 min,
2 h apart, and the apparatus and objects were cleaned with
10% ethanol between animals. In the presence of the objects,
the percentage of time spent with each object (totalizing 100%)
was measured. The analysis was done in videos acquired with
a GoPro Hero (GoPro, Inc., San Mateo, CA, USA) during
testing of 3–5 animals per group (for short-term recovery) and
12–15 animals per group (for long-term recovery), using the
Any-maze software (version 4.99, Stoelting Co., Wood Dale,
IL, USA).
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FIGURE 1 | Experimental procedures for the study of behavioral recovery and neurogenesis after kainic acid (KA) or saline (SAL) treatment. Wild type
(WT) and hCAST mice were treated with either SAL or KA (25 mg/kg, s.c.). (A) To study behavioral recovery in the short-term group, the cognitive behavior of the
animals was tested on the 3rd week after treatment. (B) For the behavioral recovery in the long-term group and the study of neuronal differentiation, mice were given
5-ethynyl-2′-deoxyuridine (EdU; 50 mg/kg, i.p.) on days 3, 4 and 5, 8 weeks before sacrifice, and the cognitive behavior was tested during the last week. (C) On the
first day, object recognition (OR) was tested. (D) Water maze (WM) trials were performed on the next 3 days and the final test, without the platform, was on day 4.
(E) On the next day, fear conditioning (FC) trials were performed. One day later, the animals were at first left on the same context and, after 3 h, the context was
completely modified and the cued test performed. The animals were sacrificed on the next day. (F) To study neural stem cell (NSC) proliferation, mice were given
5-bromo-2′-deoxyuridine (BrdU; four doses of 50 mg/kg, i.p.) on day 5, up to 12 h before sacrifice. (G) To study neuroblast migration, mice were sacrificed 14 days
after treatment.
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Morris Water Maze
To evaluate spatial learning and memory, the WM test (Morris
et al., 1982) was performed. During the first 3 days, the animals
were trained to find a platform (10 cm diameter, carved to
increase grip) hidden 0.5 cm below the water surface level in
a circular pool (1.52 m diameter), in a fixed location. Visual
cues on the walls around the pool were provided to help the
mice locating the platform and the water temperature was
maintained at 22◦C ± 1◦C. The pool was divided into four
quadrants and, on each day of training, the animals were placed
in a different quadrant, always facing the border of the pool,
under the course of four 60 s trials, 30 min apart. The latency
to escape was measured as the time each animal took to find
and climb onto the platform. If the animal did not reach the
platform within the course of the trial, the latency to escape
was considered 60 s and the animal was left on the platform
for 10 s, in order to learn the platform location. On the last
day of testing, the platform was removed and the mice were
placed in the quadrant opposite to the target quadrant (where the
platform was previously located), facing the border of the pool.
The time spent on each quadrant and the number of crossings
over the previous platform location were measured for 60 s,
to evaluate if the animals remembered where the platform was
located during training. All animals were dried under an infrared
light after each trial. The analysis was done in videos acquired
with a GoPro Hero (GoPro, Inc., San Mateo, CA, USA) during
testing of 4–5 animals per group (for short-term recovery) and
11–16 animals per group (for long-term recovery), using the
Any-maze software (version 4.99, Stoelting Co., Wood Dale,
IL, USA).
Fear Conditioning
Associative learning and memory were tested by performing
the FC test (Wehner and Radcliffe, 2004). The first day of
testing consisted of learning to associate a cue tone (80 dB)
with a footshock (0.7 mA). For this part of the test, mice were
placed in a chamber (17 × 17 × 25 cm3) with a grid floor
inside a soundproof box (Stoelting Co., Wood Dale, IL, USA),
with a background white noise, 70% ethanol scent and 100%
lux lighting (context A). After 2 min (acquisition/habituation),
the tone was played for 30 s and the footshock given during
the last 2 s of tone. This was repeated two more times, after
a 60 s rest. On the next day, the association of the context
with the footshock was tested (context test), by placing the
mice inside the chamber in the same conditions as during
learning for 5 min, without presentation of tone or footshock.
After 3 h, the association of the footshock with the tone
(cued test) was tested, by placing the animals in a completely
different environment for 3 min (habituation to new context)
and then playing the tone for the last 3 min. The new context
consisted of a background fan noise, vanilla scent, 10% lux
lighting, and the previously used chamber was altered by using
striped black and white walls and a white floor covering the
grid (context B). During the whole FC testing, the chamber
was cleaned with 10% ethanol between animals, and the fear
behavior measured by calculating the percentage of freezing
time, for 3–5 animals per group (for short-term recovery) and
9–16 animals per group (for long-term recovery), using the
Any-maze software (version 4.99, Stoelting Co., Wood Dale, IL,
USA).
NSC Proliferation
Cell proliferation after KA or SAL treatment was assessed by the
incorporation of the thymidine analog 5-bromo-2′-deoxyuridine
(BrdU), as shown in Figure 1F. WT and hCAST mice were
given either KA or SAL (9–14 animals per group) and BrdU was
administered intraperitoneally (four doses of 50mg/kg, 2 h apart)
on day 5, when a peak of proliferation is known to occur in the
DG after KA treatment (Carreira et al., 2010). The animals were
sacrificed after at least 12 h, by transcardial perfusion.
Neuroblast Migration
In order to investigate neuroblast migration after lesion, WT
and hCAST mice were given either KA or SAL (6–9 animals
per group) and sacrificed by transcardial perfusion, after 14 days
(Figure 1G), when an increase in cell migration is known to
occur in the DG after KA treatment (Carreira et al., 2015). Cell
migration in the DG was then assessed by analyzing neuroblast
staining with doublecortin (DCX), as described further in more
detail.
EdU Detection and Immunohistochemistry
Brains used for immunohistochemistry and EdU detection were
obtained after transcardial perfusion of the mice with 0.9% NaCl
and 4% paraformaldehyde. The brains were removed and kept
in 4% paraformaldehyde overnight for further fixation and then
dehydrated in 20% sucrose in phosphate buffer for at least one
day, at 4◦C. Coronal sections from the hippocampal region
were cryosectioned (30 µm thick, in 6-series) using a CryoStar
NX50 cryostat (Thermo Fisher Scientific, Waltham, MA, USA)
and stored in an antifreeze solution (30% ethylene glycol and
30% glycerol in phosphate buffer), at 4◦C. Free-floating brain
sections from one of the series were labeled against BrdU,
DCX, EdU or EdU/NeuN (neuronal nuclei), as previously
described (Morte et al., 2013; Machado et al., 2015). EdU labeling
was performed using a commercially available kit (Click-iTr
EdU Alexa Fluorr 488 HCS Assay, Thermo Fisher Scientific,
Waltham, MA, USA). After rinsing with 3% bovine serum
albumin, the sections were permeabilized with 0.5% triton
X-100 for 45 min, rinsed again and then incubated with a
reaction cocktail (reaction buffer, CuSO4, Alexa Fluor 488 and
reaction buffer additive) for 1 h, protected from light, at room
temperature. For immunohistochemistry, sections were rinsed
with PBS and then blocked for 1 h, at room temperature,
in 5% blocking solution in 0.25% triton X-100, using normal
horse serum. After blocking, the sections were kept with the
primary antibodies—rat anti-BrdU 1:50 (AbD Serotec, Oxford,
UK), goat anti-DCX 1:400 (Santa Cruz Biotechnology, Inc.,
Dallas, TX, USA), mouse anti-NeuN 1:200 (Merck Millipore,
Billerica, MA, USA)—for 48 h, at 4◦C. Sections were then
rinsed in 2% blocking solution and incubated for 2 h, at room
temperature and protected from light, with the correspondent
Alexa Fluor-conjugated secondary antibodies—donkey anti-rat
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488, donkey anti-goat 594 and donkey anti-mouse 594; 1:200
(Thermo Fisher Scientific, Waltham, MA, USA). For the
labeling of BrdU, a DNA denaturation step with 1 M HCl
for 20 min, at 65◦C, was performed in the beginning. In the
cases where NeuN was not labeled, nuclei were stained with
2 µg/ml Hoechst 33342 for 10 min, at room temperature.
For the combination of EdU and NeuN, EdU labeling was
performed, followed by the immunohistochemistry, starting with
the blocking step. The entire procedure was done using an orbital
shaker. After a final rinsing step, the sections were mounted
in gelatin-coated slides, with DAKO fluorescence mounting
medium.
Analysis of Incorporation of BrdU and EdU
For the analysis of incorportation of the thymidine analogs,
BrdU-positive and EdU-positive cells in the SGZ, the first layer of
cells adjacent to the hilus, in the GZ or in the hilus of five central
coronal sections of the hippocampal region were counted for
each animal (Salazar-Colocho et al., 2008; Machado et al., 2015),
directly under an epifluorescence microscope (Axio Imager
Z2 microscope, Zeiss, Oberkochen, Germany). Cell counting was
carried out in both upper and lower blades of the DG.
DCX Immunoreactivity
DCX immunoreactivity in the DG was determined in images
acquired in a laser scanning microscope (LSM710, Zeiss, Jena,
Germany). The quantification of the DCX-positive area was
performed in ImageJ (version 1.47v, National Institutes of
Health, Bethesda, MD, USA), using a threshold analysis in five
central coronal sections of the hippocampal region of each
animal. This consisted in defining the optimal staining threshold
and calculating the area labeled with DCX (Komitova et al., 2005;
Machado et al., 2015).
Neuronal Differentiation Analysis
For the quantification of newborn neurons, the percentage of
cells labeled for both EdU and NeuN was determined in a total
of up to 50 EdU-positive cells (Carreira et al., 2015) in the DG of
eight animals per group, in images (orthogonal reconstructions
of projections from 0.73 µm z-stacks) acquired in a LSM710
(Zeiss, Jena, Germany).
FluoroJade C Staining
For FluoroJade C staining, coronal sections from the
hippocampal region of WT and hCAST mice (3–4 animals
per group) treated with KA for 24 h were mounted in gelatin-
coated slides. After air-drying for at least 24 h, the sections were
rinsed twice in distilled water, and then immersed for 5 min in
0.1% sodium hydroxide prepared in 80% ethanol, 1 min in 70%
ethanol and rinsed twice for 2 min in distilled water. The slides
with the sections were then transferred to a 0.06% potassium
permanganate solution and left in an orbital shaker for 10 min.
After another rinsing step, the slides were left with agitation
and protected from light for 10 min in 0.0001% FluoroJade C
prepared in 0.1% acetic acid. The sections were rinsed three more
times for 1 min in distilled water and dried for 15 min at 60◦C,
after which they were immersed in xylene and coverslipped
with DPX mounting medium. Images were acquired in an
epifluorescence microscope (Axio Imager Z2 microscope, Zeiss,
Oberkochen, Germany) and the percentage of staining in the
GZ and the hilus measured using a threshold analysis in ImageJ
(version 1.47v, National Institutes of Health, Bethesda, MD,
USA; Carreira et al., 2010; Machado et al., 2015).
Statistical Analysis
Data are expressed as means ± SEM. Statistical significance was
determined using the Kruskal-Wallis test, with Dunn’s post-test,
or the Mann-Whitney test, as indicated in the figure legends,
using the GraphPad Prism 5 software (GraphPad Software, Inc.,
La Jolla, CA, USA). Differences were considered significant when
p < 0.05.
RESULTS
Short-Term Impairment in Novel Object
Exploration after KA Treatment Is
Prevented in Mice Overexpressing CAST
To evaluate whether CAST overexpression would allow for a
better and/or faster recovery after brain injury, we performed
several cognitive behavioral tests on WT and hCAST mice, on
the 3rd (short-term) or 8th (long-term) week after treatment
with either KA or SAL. We first tested the animals for OR
memory (3–5 animals per group for short-term recovery and
12–15 animals per group for long-term recovery). We observed
that, for both time periods, WT mice treated with SAL spent
significantly more time exploring the novel object (short-term
recovery: 58.3 ± 3.7%, long-term recovery: 62.9 ± 3.3%) than
the familiar object, that they had already explored previously
(short-term recovery: 41.7± 3.7%, p < 0.05, long-term recovery:
37.1 ± 3.3%, p < 0.001). However, after KA treatment, only
WT mice from the long-term recovery group were able to
distinguish the novel object (58.9 ± 4.5%), from the familiar
object (41.1 ± 4.5%, p < 0.05; Figure 2, left panels), indicating
impairment in recognition memory in the short-term group.
On the other hand, all mice overexpressing CAST spent more
time exploring the novel object, in both short-term recovery
(SAL, novel object: 61.5 ± 5.0%, familiar object: 38.5 ± 5.0%,
p > 0.05; KA, novel object: 61.1 ± 1.3%, familiar object:
34.9 ± 1.3%, p < 0.01) and long-term recovery (SAL, novel
object: 62.9 ± 3.8%, familiar object: 37.1 ± 3.8%, p < 0.001; KA,
novel object: 59.7± 3.6%, familiar object: 40.3± 3.6%, p< 0.001;
Figure 2, right panels).
Long-Term Impairment in Spatial Memory
for an Exact Location during the Water
Maze Test after KA Treatment Is Prevented
in Mice Overexpressing CAST
In order to study spatial learning and memory, the Morris
WM test was performed (4–5 animals per group for short-term
recovery and 11–16 animals per group for long-term recovery).
During trials (Figure 3A), we observed that KA-treated mice
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FIGURE 2 | KA-treated WT mice present short-term impairment in novel object exploration, but not KA-treated hCAST mice. WT and hCAST mice
behavior was tested on the 3rd (short-term) or 8th week (long-term) after treatment with either SAL or KA. Recognition memory was assessed by measuring the
percentage of exploration time during the presentation of a novel object, in the OR test. Data are presented as means ± SEM of 3–5 animals per group (for
short-term recovery) and 12–15 animals per group (for long-term recovery). Statistical significance was determined using the Kruskal-Wallis test (Dunn’s post-test),
∗p < 0.05, ∗∗p < 0.01 and ∗∗∗p < 0.001, significantly different from familiar object.
in the short-term recovery period learned the platform location
similarly to SAL on all days (Day 1, WT: 49.3 ± 7.3 s, hCAST:
39.4 ± 4.1 s; Day 2, WT: 36.3 ± 10.0 s, hCAST: 15.5 ± 3.6 s;
Day 3, WT: 24.2 ± 10.9 s, hCAST: 14.2 ± 4.7 s, p > 0.05), as
well as all KA-treated mice in the long-term recovery period
(Day 1, WT: 38.4 ± 2.7 s, hCAST: 47.9 ± 2.7 s; Day 2, WT:
26.4 ± 3.9 s, hCAST: 30.9 ± 5.3 s; Day 3, WT: 17.4 ± 4.9 s,
hCAST: 20.7± 2.1 s, p> 0.05). All mice showed improved spatial
learning over the course of the trials.
After learning the platform location, the platform was
removed and the spatial memory evaluated by calculating the
percentage of time spent in the target quadrant (where the
platform previously was) and by counting the number of
crossings through the exact previous platform location. Time
spent in the target quadrant was maintained with KA treatment
in both time periods, by comparison with SAL (short-term
recovery, WT: 60.4 ± 3.7%, hCAST: 49.0 ± 5.7%, p > 0.05;
long-term recovery, WT: 56.4 ± 4.1%, hCAST: 49.0 ± 4.3%,
p > 0.05; Figure 3B, left panels), indicating that all animals
remembered the relative position of the platform. The number
of platform crossings (Figure 3B, right panels), in turn, also
seemed to be maintained with KA treatment in the short-term
recovery period when comparing to SAL (WT: 4.3± 1.6, hCAST:
3.8 ± 0.9, p > 0.05). However, in the long-term recovery period,
the number of platform crossings was significantly impaired
in KA-treated WT mice (2.4 ± 0.4) by comparison with SAL
treatment (4.5 ± 0.7, p < 0.05), indicating increased difficulty in
remembering the exact platform location, which is not observed
in mice overexpressing CAST (SAL: 3.0± 0.6, p > 0.05).
Associative Fear Memory Is Preserved
after KA Treatment
Lastly, associative learning and memory was evaluated, by
performing the FC test (3–5 animals per group for short-term
recovery and 9–16 animals per group for long-term recovery).
By the end of the trials, on the first day, the animals successfully
learned to associate the cue tone with a footshock. All animals
spent nearly half the time of the last hearing of the tone freezing,
both in the short-term recovery (WT SAL: 42.7 ± 5.4%, hCAST
SAL: 51.5 ± 5.3%, p > 0.05) and in the long-term recovery
(WT SAL: 48.9 ± 6.8%, hCAST SAL: 47.1 ± 4.5%, p > 0.05;
Figure 4A).
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FIGURE 3 | Spatial memory for the exact platform location is impaired in KA-treated WT mice from the long-term recovery period. WT and hCAST mice
behavior was tested on the 3rd (short-term) or 8th (long-term) week after treatment with either SAL or KA. (A) Spatial learning was assessed by measuring the
escape latency on the first 3 days of WM (four trials per day, latency of 60 s if the platform was not reached). (B) Spatial memory was assessed by measuring the
percentage of time spent on the target quadrant and the number of crossings in the exact location the platform was during trials, on the last day of WM.
Representative images of occupancy track plots for each group are shown in the top panels. Data are presented as means ± SEM of 4–5 animals per group (for
short-term recovery) and 11–16 animals per group (for long-term recovery). Statistical significance was determined using the Kruskal-Wallis test (Dunn’s post-test),
∗p < 0.05, significantly different from SAL.
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FIGURE 4 | Associative fear memory is preserved after KA treatment. WT and hCAST mice behavior was tested on the 3rd (short-term) or 8th (long-term)
week after treatment with either SAL or KA. (A) Associative learning was assessed by measuring the percentage of freezing time during FC trials, with the delivery of
a footshock by the end of each cue tone. Acqui. (acquisition). (B) Associative memory to the context and cue tone were assessed by measuring the percentage of
freezing time during the FC context test (context A) and cued test (cued stimulus), in a new context (context B). Data are presented as means ± SEM of 3–5 animals
per group (for short-term recovery) and 9–16 animals per group (for long-term recovery). Statistical significance was determined using the Kruskal-Wallis test (Dunn’s
post-test), p > 0.05 between treatments.
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FIGURE 5 | KA treatment enhances NSC proliferation and neuroblast migration in the dentate gyrus (DG). (A) Representative image of a section of the
DG, showing the division into granular zone (GZ), subgranular zone (SGZ) and hilus. EdU in green and nuclei, stained for Hoechst 33342, in gray. Scale bar: 50 µm.
(B) WT and hCAST mice were treated with either SAL or KA and were given BrdU on the day before sacrifice, to assess cell proliferation. Representative images from
hippocampal brain sections for each group (left panels), showing BrdU-positive cells in white. Scale bar: 200 µm. BrdU-positive cells were counted in the SGZ of five
central coronal sections of the hippocampal region for each animal (right panel). (C) WT and hCAST mice were treated with either SAL or KA and sacrificed after
14 days, to assess cell migration. Representative images from hippocampal brain sections for each group (left panels), showing migrating neuroblasts, labeled for
doublecortin (DCX), in white. Scale bar: 100 µm. Percentage of DCX-positive area was determined in the DG of five central coronal sections of the hippocampal
region for each animal (right panel). Data are presented as means ± SEM of 9–14 animals per group (for cell proliferation) and 6–9 animals per group (for cell
migration). Statistical significance was determined using the Kruskal-Wallis test (Dunn’s post-test), ∗p < 0.05, ∗∗p < 0.01 and ∗∗∗p < 0.001, significantly different
from SAL.
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When tested for associative memory to context (context
A; Figure 4B, left panels), all KA-treated mice seemed to
recognize the context similarly to SAL, both in the short-term
recovery (WT: 48.9 ± 6.8%, hCAST: 64.2 ± 10.8%, p > 0.05)
and in the long-term recovery (WT: 51.5 ± 6.0%, hCAST:
69.4 ± 2.6%, p > 0.05). When in the context meant for the
cued test (context B; Figure 4B, middle panels), all hCAST
mice from the short-term recovery group treated with KA
spent over half the time freezing (SAL: 37.4 ± 7.2%, KA:
63.4 ± 9.8%, p > 0.05), while the percentage of freezing time
was maintained low in WT mice (SAL: 23.1 ± 4.5%, KA:
23.5 ± 5.7%, p > 0.05). In the long-term recovery group, the
percentage of freezing time was more similar to SAL in both
WT and hCAST mice (WT: 25.4 ± 4.4%, hCAST: 33.8 ± 4.4%,
p > 0.05). Moreover, all KA-treated mice seemed to maintain
the associative memory to the cued stimulus by comparison with
SAL, both in the short-term recovery (WT: 56.7± 3.9%, hCAST:
75.5 ± 5.2%, p > 0.05) and in the long-term recovery (WT:
69.1 ± 6.5%, hCAST: 75.1 ± 3.2%, p > 0.05; Figure 4B, right
panels).
CAST Overexpression Maintains
Enhancement of Early Hippocampal
Neurogenesis after KA Treatment
In order to study the effects of CAST overexpression on
the early stages of hippocampal neurogenesis after a brain
insult, NSC proliferation and neuroblast migration were
analyzed in the DG of adult mice (Figure 5A), after treatment
with either SAL or KA (9–14 animals per group for cell
proliferation and 6–9 animals per group for cell migration).
Cell proliferation was assessed by incorporation of the
thymidine analog BrdU into the DNA of dividing NSCs
from the SGZ of the hippocampus. We observed that cell
proliferation was greatly enhanced in mice overexpressing
CAST after KA treatment (73.1 ± 8.0 cells/section), when
compared to SAL-treated mice (19.2 ± 1.5 cells/section,
p < 0.001), similarly to what was seen in WT mice (KA:
75.6 ± 9.7 cells/section, SAL: 25.0 ± 2.5 cells/section, p < 0.01;
Figure 5B).
With regard to neuroblast migration, as assessed by DCX
staining in the DG, we also observed a significant increase
in KA-treated mice overexpressing CAST (6.1 ± 0.6%), when
compared to SAL-treated mice (1.9 ± 0.2%, p < 0.05). Although
cell migration in the DG of KA-treated WT mice (8.5 ± 0.3%)
was also enhanced in comparison with SAL (2.1 ± 0.2%,
p < 0.001), CAST overexpression seemed to attenuate this effect
(Figure 5C).
To evaluate whether differences in neuronal death after
lesion could be observed, WT and hCAST mice (3–4 animals
per group) were sacrificed 24 h after KA treatment and
FluoroJade C staining was performed. We observed that
hCAST mice presented an amount of dying neurons similar
to WT mice in the DG, both in the GZ (WT: 0.1 ± 0.1%,
hCAST: 0.2 ± 0.0%, p > 0.05) and in the hilus (WT:
0.3 ± 0.2%, hCAST: 0.5 ± 0.1%, p > 0.05; Supplementary
Figure 1).
CAST Overexpression Affects Cell
Differentiation in the DG Similarly to WT
after KA Treatment
Besides cell proliferation and migration, we were also
interested in investigating differentiation of newborn cells
after treatment with KA. For that purpose, mice were
treated with the thymidine analog EdU (eight animals per
group), and the number of EdU-positive cells remaining
in the DG after 8 weeks was counted. We observed that
the number of newborn cells still surviving in the DG was
generally enhanced with KA-treatment in WT (SGZ + GZ:
9.7 ± 1.8 cells/section, hilus: 1.6 ± 0.3 cells/section) and hCAST
(SGZ + GZ: 9.2 ± 1.1 cells/section, hilus: 1.6 ± 0.3 cells/section)
mice, when compared to SAL treatment (SGZ + GZ, WT:
1.8 ± 0.1 cells/section, p < 0.01, hCAST: 1.6 ± 0.3 cells/section,
p < 0.001; hilus, WT: 0.3 ± 0.1 cells/section, p < 0.01,
hCAST: 0.6 ± 0.2 cells/section, p > 0.05; Figure 6A). When
assessing neuronal differentiation specifically, by determining
the percentage of those cells that colocalized with a neuronal
marker (NeuN), we observed that treatment with KA seemed
to reduce the amount of new neurons in the DG in WT mice
(52.5 ± 8.0%) and in mice overexpressing CAST (47.0 ± 4.1%),
when compared to SAL-treated animals (WT: 71.6 ± 4.4%,
p > 0.05; hCAST: 67.2 ± 4.2%, p < 0.05; Figure 6B), suggesting
decreased neuronal survival.
DISCUSSION
The realization that the adult mammalian brain is not an
immutable organ and that new neurons are able to form and
thrive in the neuronal circuitry has opened new doors for the
putative treatment of neurodegenerative disorders and brain
lesions. NSCs not only give origin to new neurons in the healthy
brain, but are also known to increase the formation of new
cells after lesion. NSCs can travel as neuroblasts into regions
where neurons were lost as a consequence of brain damage, in
what seems like an endogenous attempt to replace those lost
neurons. However, this process is not very efficient, as most
of the new cells die, fail to integrate the networks, or do it
erroneously (Kaneko and Sawamoto, 2009; Ma et al., 2009).
While cell transplantation into the sites of injury, for example,
also seems promising, modulating endogenous neurogenesis
would offer a less invasive approach for the treatment of brain
damage. Calpains are proteases involved in neurodegeneration
and their inhibition has been shown to be neuroprotective
in several diseases (Saez et al., 2006), though their influence
in neurogenesis is still not very clear. One of the approaches
for the study of calpains is the modulation of their selective
endogenous inhibitor, CAST. We had previously seen that the
absence of CAST impairs NSC proliferation and neuroblast
migration in the adult mouse brain (Machado et al., 2015),
namely hippocampal neurogenesis, which has been implicated in
learning and memory. Thus, we were interested in investigating
whether overexpressing CASTwould improve cognitive recovery
after hippocampal injury, induced with KA, and its effects on
post-injury neurogenesis. Finding a way to modulate calpain
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FIGURE 6 | CAST overexpression affects cell differentiation in the DG similarly to WT after KA treatment. WT and hCAST mice were treated with either
SAL or KA and sacrificed 8 weeks after EdU administration, to assess neuronal differentiation. (A) Representative images from hippocampal brain sections for each
group (top panels), showing EdU-positive cells in white. Scale bar: 200 µm. EdU-positive cells were counted in the SGZ, GZ and hilus of five central coronal sections
of the hippocampal region for each animal (bottom panels). (B) Representative images from hippocampal brain sections of EdU-positive/neuronal nuclei
(NeuN)-positive and EdU-positive/NeuN-negative cells in the DG (top panels), showing cells labeled for EdU in green and cells labeled for NeuN in red. Scale bar:
5 µm. The percentage of cells labeled for both EdU and NeuN in the DG (bottom panel) was determined in a total of up to 50 EdU-positive cells. Data are presented
as means ± SEM of eight animals per group. Statistical significance was determined using the Kruskal-Wallis test (Dunn’s post-test), ∗p < 0.05, ∗∗p < 0.01 and
∗∗∗p < 0.001, significantly different from SAL.
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activity in order to help improve the outcome of brain injury
would highly benefit patients with neurodegenerative diseases or
other types of brain insults.
KA induces excitotoxicity and consequent cell death,
by activating ionotropic receptors highly abundant in the
hippocampus (Wang et al., 2005; Carta et al., 2014). The KA
model of brain lesion is thus often used for research involving
hippocampal damage, especially in studies of temporal lobe
epilepsy (Levesque and Avoli, 2013). It is also a good model for
investigating hippocampal injury and its consequences (Araújo
et al., 2008; Carreira et al., 2010, 2015). Since the hippocampus
is the main structure involved in learning and memory, it is
not surprising that treatment with KA in rodents can induce
cognitive impairment (Stubley-Weatherly et al., 1996), which
has also been reported in patients with temporal lobe epilepsy
(Hattiangady and Shetty, 2008). With this in mind, we were
especially interested in verifying whether mice overexpressing
CAST would show differences in cognitive recovery on the
3rd (short-term) or 8th week (long-term) after KA treatment.
In the short-term group, neurons born a few days after the
brain insult are still immature, while in the long-term group
those neurons are already fully mature and integrated (Deng
et al., 2010). We tested the mice for three different types of
cognitive behavior: recognition memory (OR), spatial learning
and memory (WM) and associative learning and memory
(FC).
The OR test makes use of the natural exploratory behavior of
rodents. In the presence of a familiar and a novel object, rats
and mice will normally spend relatively more time exploring
the novel one, in a process shown by several studies to
implicate the hippocampus (Cohen and Stackman, 2015). It was
thus not a surprise that KA treatment impaired recognition
of the previously explored object in WT mice from the
short-term recovery group. In the long-term group, however, this
impairment seemed to be overcome, suggesting that the newly
formed cells ultimately succeeded in restoring the networks
necessary for OR. Interestingly, CAST overexpression prevented
impairment after KA treatment even in the short-term group.
Having in mind that in this group the newly formed neurons
are still immature, it is unlikely that they were already able to
restore lost connections. This might thus mean that the regions
involved in recognition memory were less affected when CAST
was overexpressed.
Spatial memory, in turn, has long been known to require the
hippocampus, being one of the most affected by hippocampal
lesions (Best et al., 2001; Martin and Clark, 2007). In a
fundamental work by Richard Morris (Morris et al., 1982),
for example, rats with hippocampi removed took longer to
learn to reach an escape platform hidden in a pool, but not a
visible platform, and also had more difficulty in distinguishing
the exact previous escape location when the platform was
removed from the pool. This indicates the importance of the
hippocampal integrity in navigating through space using only
distal environmental cues. In our study, we used this Morris
WM test to investigate whether impairment in spatial memory
was also seen in our model and if CAST overexpression could
be beneficial. By the end of the trials, all animals were able to
learn to reach the platform, and also spent a high percentage
of time in the target quadrant when platform was removed.
Moreover, in the short-term group, there seemed to be no
differences in the number of crossings over the exact previous
platform location. In the long-term group, however, the number
of crossings was impaired in KA-treatedWTmice in comparison
with SAL, which was not seen in mice overexpressing CAST.
Interestingly, certain neurons in the hippocampus, the place
cells, have the peculiarity of firing only when the animal enters
a specific position in space. Different place cells respond to
different locations of the same environment, allowing the brain
to create a spatial map of that particular environment (O’Keefe
and Dostrovsky, 1971). Additionally, a study on the pattern of
place-cell activity during a WM test in rats has shown that the
percentage of place cells firing maximally was more than doubled
near the platform when compared to other locations in the pool
(Hollup et al., 2001). This indicates a great contribution of these
cells to the correct mental positioning of the platform in this
particular task. Our results may suggest a loss of place cells or
correct place-cell activity inWTmice treated with KA, since they
seemed to have only a general idea of the platform whereabouts,
but failed to determine exactly where it was, as compared
to SAL-treated mice. This notion is further corroborated by
a study showing that seizure-induced hippocampal lesion can
indeed affect the activity of place cells several weeks later,
making them less precise and less stable (Liu et al., 2003). The
existing place cells in mice overexpressing CAST seem therefore
to be less affected by KA treatment, suggesting that calpain
inhibition may also limit the seizure-induced damage of these
cells.
The FC test was the last to be performed, since it was the most
stressful for the animals. This test is based on the association
of an aversive stimulus with a tone and with the context
where it occurred, which is measured by the time the animal
spends freezing, i.e., when the only observed movement is from
breathing, a known indicative of fear in rodents (Blanchard and
Blanchard, 1969; Wehner and Radcliffe, 2004). As with the other
performed cognitive tests, the FC test also has the involvement
of the hippocampus, but only in relation to context, being the
response to the cued stimulus dependent on the integrity of the
amygdala (Phillips and LeDoux, 1992). For that reason, during
learning, we were expecting all mice to associate the cued tone
with the aversive stimulus, with progressively more time spent
freezing with further tone presentations. Indeed, by the last time
the tone was played, all animals spent around half of the time
freezing, in contrast with virtually no freezing that was observed
when they were first placed in the chamber. On the following
day, the animals were placed in the exact same context, without
presentation of tone or footshock, and SAL-treated animals
presented associative memory to this context, by presenting
freezing behavior for most of the time spent inside the chamber,
as expected. However, KA-treatment failed to impair the time
spent freezing, which may be linked with the relative resistance
of the used strain to KA-induced cell death (McKhann et al.,
2003). Even though differences in associative memory might
be too subtle for detection, freezing to the modified context
seemed to be increased in KA-treated mice overexpressing CAST
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from the short-term recovery group, since they spent over
half the time freezing. Unlike the other mice, that seemed to
understand the context was different, these mice seemed to
assimilate that they were in a similar situation as before. One
interesting feature of the aforementioned place cells is that
they can be involved in the mechanisms of pattern separation,
the ability to discriminate between very similar memories, and
pattern completion, the ability to recall a previous memory in
full based only on some of the components that composed
that memory (Sahay et al., 2011). If these mechanisms are
not balanced, there is an alteration in the perception of the
environment. For instance, if pattern completion is relatively
enhanced, there is generalization of the current environment,
which means that several contexts may be linked together, even
if they present reduced similarities (Sahay et al., 2011). This
imbalance may thus be what caused the tendency of KA-treated
hCAST mice from the short-term group to present higher
freezing in the modified context, since the small similarities
between both contexts could have been enough for them to
recall the aversive stimulus. A possible explanation for this
may relate to the findings that young granule cells (immature
neurons) seem to be involved with pattern separation and
older granule cells with pattern completion (Nakashiba et al.,
2012). Assuming that old neurons can be more resistant, and
that this might be the case in KA-treated mice overexpressing
CAST, relatively more younger ones would die (Spalding et al.,
2013). Since KA enhances the early stages of neurogenesis, an
increased number of younger granule cells is expected to exist
in the hippocampus of mice from the short-term group. At
first, the new cells do not appear to be enough to compensate
for the relative higher number of older cells, though later on
they seem to regain balance, since the differential behavioral
response to the new context of hCAST mice treated with KA
from the short-term recovery group is lost in the long-term
group. On the other hand, assuming that in WT mice younger
and older neurons are lost more or less equally in KA-treated
WT mice, and since the balance between younger and older
granule cells seems to be maintained, by observation of memory
association to the new context, we suggest that the new young
neurons may not be fully functional. Electrophysiology studies
would help to evaluate if this is in fact the case. Lastly, like
with learning, we were expecting, and observed, associative
memory to the cue tone to be maintained in all animals,
since the hippocampus does not seem to be involved in this
process.
Furthermore, we wanted to evaluate whether CAST
overexpression affected the modulation of post-injury
hippocampal neurogenesis. Like with other types of brain
damage, an enhancement of endogenous neurogenesis has
also been reported after seizures. Independently of the model
chosen to induce seizures in rodents, NSC proliferation is
specially shown to be largely increased in the DG after just
a few days (Parent et al., 1997; Gray and Sundstrom, 1998;
Nakagawa et al., 2000; Hüttmann et al., 2003; Mohapel et al.,
2004; Jessberger et al., 2007; Sierra et al., 2015). Interestingly,
evidence of increased cell proliferation has also been observed
in the hippocampus of patients with temporal lobe epilepsy
(Blümcke et al., 2001; Crespel et al., 2005). In the model used by
our group, the peak of cell proliferation in the DG was shown
to occur on day 5 after seizure induction, with a significant
increase in neuroblast migration after 14 days (Carreira et al.,
2015), results that we were able to replicate in the present
work. This heavy enhancement of early neurogenesis indicates
that the microenvironment in the hippocampus not long
after seizures is extremely pro-neurogenic, which makes it
difficult for changes due to altered levels of calpain activity to
be observed. Nonetheless, since increased calpain activity can
impair NSC proliferation and migration of neuroblasts, it is
important to exclude whether, in this case, calpain inhibition,
by overexpression of CAST, increases cell proliferation and
migration to alarming levels. An even more extreme rise in
cell proliferation could originate unwanted cellular masses of
undifferentiated cells, and more migrating cells could also mean
more cells migrating into ectopic regions, interfering with the
normal neuronal networks (Parent et al., 2006).
Regarding cell proliferation, the enhancement observed
after KA treatment was similar in WT mice and in mice
overexpressing CAST. Curiously, however, while the increase in
neuroblast migration in KA-treatedWTmice was around 4-fold,
it dropped to 3-fold with the overexpression of CAST. Brain
damage is closely associated with an increase in calpain activity,
and it is known that calpain inhibition can be neuroprotective
(Saez et al., 2006). This means that the fact that CASTwas already
overexpressed when seizures were induced may have attenuated
the damage. Even though the amount of dying neurons in the DG
24 h after KA treatment seems similar to WT in a preliminary
study by our group, the surrounding circuitry may still be
more preserved with CAST overexpression, or different types
of neurons may be affected. Less damage could therefore also
mean a less dramatic increase in neurogenesis. In the long term
this could be favorable, proven that more cells would integrate
correctly in the existing networks. Cell proliferation in the DG
was shown by another group to substantially rise even after less
severe seizures, with no further increase with seizure severity
(Mohapel et al., 2004). This might explain why we observed a
similar increase in cell proliferation even with the overexpression
of CAST.
This increase in neurogenesis after lesion, however, is only
efficient if the new cells ultimately differentiate, survive and
integrate the neuronal circuitry correctly. After seizures, this is
usually not the case. Despite the enhancement in the early stages
of neurogenesis, most of the new cells end up differentiating
into astrocytes, with relatively less neurons surviving 1–2 months
after seizures (Hattiangady and Shetty, 2010; Carreira et al., 2015;
Sierra et al., 2015). Moreover, several newly formed neurons
resembling granule cells are found ectopically in the hilus, and
have also been reported to occur in patients with temporal lobe
epilepsy (Parent et al., 1997, 2006). These ectopic granule-like
hilar cells are hyperexcitable, contributing to a disruption of
the existing neuronal networks and possibly aggravating the
outcome of the disease (Dashtipour et al., 2001; Cameron
et al., 2011). Our findings with WT mice are consistent with
what has been reported. After a 2-month period, there were
significantly more new cells found in the hilus, SGZ and GZ
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of the DG of mice treated with KA. Though not significant,
the percentage of new neurons seemed to be decreased in
these mice, which is in accordance with the aforementioned
reduced survival of new neurons after seizures. The overall
increase in the number of new cells may thus be justifiable by
the increased differentiation into astrocytes that occurs after
seizures. The results obtained with hCAST mice were very
similar, indicating that suppression of calpain activity provided
by CAST overexpression is not enough to compensate for the
impairment of neuronal differentiation in the DG. Although
calpain inhibition was shown to increase neuronal differentiation
in vitro, in a cell line from fetal NSCs (Santos et al., 2012),
we cannot exclude that in vivo and in the developed brain
other mechanisms may compensate for the decrease in calpain
activity under a certain threshold, or even help in maintaining
levels of calpain activity too elevated, especially in a pathologic
environment. In this case, additional factors, such as nitric oxide
from inflammatory origin, may also contribute for neuronal
impairment (Carreira et al., 2015). This multifactorial feature
of brain pathology must thus be taken into account when
developing new strategies for brain repair. Nonetheless, even
though the percentage of neurons formed after seizures is not
ameliorated by CAST overexpression, the ones that thrive may
still be more functional and better integrated in the hippocampal
neuronal networks.
Overall, the fact that CAST was already overexpressed prior to
lesion may have masked potential benefits of calpain inhibition
on post-injury neurogenesis. Moreover, the fact that the absence
of CAST and, consequently, increased calpain activity, can impair
hippocampal neurogenesis, does not necessarily mean that
reduced or lack of calpain activity can enhance it. In conclusion,
even though reduced calpain activity does not seem to be able to
enhance hippocampal neurogenesis, it could potentially be able
to prevent the impairment in the formation of new neurons after
injury, given that the levels of calpain activity could be reduced
under a certain threshold. Strategies to reduce the harmful
effects of the pathologic environment, such as controlling
neuroinflammation, could also help boost the outcome of calpain
inhibition in the survival of new neurons. Moreover, these
observations are in regard to hippocampal neurogenesis. Cells
derived from the subventricular zone may hold more promise
for the enhancement of endogenous neurogenesis with calpain
inhibition, encouraging further research involving these cells and
calpain activity in the field of brain damage.
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